A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Researchers are looking for a better way to treat children who have heart failure with
left ventricular systolic dysfunction (LVSD). Heart failure is a serious condition where
the heart is unable to pump enough blood to meet the body's needs. This can lead to
symptom...
Age: 6 months - 17 years
Gender: All
Enhancing Heart Allograft Function With the OCS Heart System Trial
This trial is designed to evaluate the safety and effectiveness of the novel OCS Solution and OCS Functional Enhancer (OFE) to support FDA approval in both DBD and DCD heart transplantation. In addition, this trial will evaluate the performance of the novel OCS Solution...
Age: 18 years - 66+
Gender: All
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the
risk for coronary heart disease death (CHD death), myocardial infarction, or urgent
coronary revascularization in participants at risk for a first major cardiovascular event
wit...
Age: 50 - 105 years
Gender: All
Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
This is a multi-center, prospective, observational study designed to evaluate the impact
of LV myocardial fibrosis extent assessed by CMR on LV reverse remodeling and clinical
outcomes post TEER. The target sample will be up to 125 patients enrolled to achieve 100
ev...
Age: 18 years - 66+
Gender: All
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
This trial will examine if maridebart cafraglutide as an adjunct to standard of care will
lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent
HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with
...
Age: 18 - 99 years
Gender: All
Transcranial Magnetic Stimulation in Misophonia
The purpose of the project is to assess the efficacy of parietal transcranial magnetic
stimulation in misophonia. N=60 participants will undergo two transcranial magnetic
stimulation sessions: one inhibitory and another excitatory. During both sessions, the
parietal ...
Age: 18 - 55 years
Gender: All
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation
Atrial fibrillation (AF) affects 1 in 4 individuals during their lifetime and continues
to increase in frequency and impact. Exercise intervention has established benefits to
improve AF symptoms and burden in clinical studies. However, lack of access to exercise
prog...
Age: 18 years - 66+
Gender: All
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
This study is open to adults with chronic heart failure (HF) who have a reduced left
ventricular ejection fraction (LVEF) of less than 40%. People can join the study if they
have been diagnosed with chronic HF at least 3 months before the study. The purpose of
this s...
Age: 18 years - 66+
Gender: All
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
This real-world, international registry aims to evaluate the current experience with
sodium-glucose cotransporter 2 inhibitors (SGLT2i) in adult congenital heart disease
(ACHD) patients by investigating the prescription patterns, safety, tolerability, and
potential b...
Age: 18 years - 66+
Gender: All
Onyx™ Liquid Embolic IDE Clinical Study
The purpose of this study is to evaluate the safety and effectiveness of Onyx™ LES in the
treatment of subjects with active arterial bleeding in the peripheral vasculature outside
of the heart and brain.
Age: 22 years - 66+
Gender: All
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Sphere-9 VT EFS is a prospective, multi-center, non-randomized, unblinded feasibility
study. Adult subjects with recurrent, sustained, scar-related monomorphic ventricular
tachycardia will be enrolled and treated with the Sphere-9 Catheter and Affera Ablation
System.
Age: 18 - 85 years
Gender: All
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
This prospective, multicenter, cluster-randomized controlled study aims to evaluate the
accuracy of an investigational artificial intelligence (AI) Software as a Medical Device
(SaMD) designed to compute ejection fraction (EF) severity categories based on the
America...
Age: 18 years - 66+
Gender: All
Antithrombotic Activities of Sotagliflozin vs. Empagliflozin
The availability of Sodium-glucose cotransporter-2 inhibitors (SGLT2-i) has dramatically altered the management of heart failure (HF) patients, independently of their ejection fraction and glycemic status. A meta-analysis of 57 studies comparing SGLT2-I monotherapy vs. ...
Age: 18 years - 66+
Gender: All
Abbott Structural Heart Device Registry
The Abbott Structural Heart (SH) Registry is being conducted to confirm the safety and performance of Abbott's SH devices in a post-market, real-world setting. The Registry primarily involves gathering data from routine hospital practices and standard-of-care (SOC) proc...
Age: Birth - 66+
Gender: All
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)
Recent retrospective studies have demonstrated differences between pulse oximeter values
(SpO2) and measured arterial oxygen saturation (SaO2) in patients identifying as Black or
Hispanic. These retrospective studies have limitations because self-reported race is
lik...
Age: Birth - 18 years
Gender: All
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin
(TTR) protein falls apart and forms amyloid, a sticky plaque- like substance that
accumulates in different organs in the body and can cause damage to the organ. There are
two way...
Age: 18 - 75 years
Gender: All
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
The purpose of this study is to demonstrate the safety and 12-month effectiveness of the
BWI OMNYPULSE™ pulsed field ablation (PFA) platform for pulmonary vein isolation (PVI) in
the treatment of participants with symptomatic paroxysmal atrial fibrillation (PAF), an
...
Age: 18 - 80 years
Gender: All
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
This is a research study in minorities to compare the outcomes of two procedures that
restore blood flow to the arteries of the heart. In one procedure the blockages are
ballooned and then stented with a small wire mesh tube through a small incision in the
wrist or t...
Age: 18 years - 66+
Gender: All
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
This is a research study in women to compare the outcomes of two procedures that restore
blood flow to the arteries of the heart. In one procedure the blockages are ballooned and
then stented with a small wire mesh tube through a small incision in the wrist or the
gr...
Age: 18 years - 66+
Gender: All
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/m^2 or higher and Atherosclero...
Age: 45 years - 66+
Gender: All